Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1982 1
1985 1
1989 1
1990 1
1991 2
1992 5
1993 1
1994 3
1995 3
1996 5
1997 4
1998 13
1999 7
2000 17
2001 19
2002 24
2003 16
2004 29
2005 41
2006 52
2007 67
2008 77
2009 73
2010 77
2011 92
2012 95
2013 116
2014 121
2015 109
2016 95
2017 117
2018 114
2019 142
2020 183
2021 193
2022 223
2023 196
2024 148

Text availability

Article attribute

Article type

Publication date

Search Results

2,154 results

Results by year

Filters applied: . Clear all
Page 1
Bifidobacterium animalis subsp. lactis HN019 Effects on Gut Health: A Review.
Cheng J, Laitila A, Ouwehand AC. Cheng J, et al. Front Nutr. 2021 Dec 14;8:790561. doi: 10.3389/fnut.2021.790561. eCollection 2021. Front Nutr. 2021. PMID: 34970580 Free PMC article. Review.
This review investigates the roles of Bifidobacterium animalis subsp. lactis HN019 (B. lactis HN019) on gut health, and its mechanisms of action in various pre-clinical and clinical studies. ...B. lactis HN019 is thus a probiotic that can contri …
This review investigates the roles of Bifidobacterium animalis subsp. lactis HN019 (B. lactis HN019) on gut heal …
Bifidobacterium animalis subsp. lactis 420 for Metabolic Health: Review of the Research.
Uusitupa HM, Rasinkangas P, Lehtinen MJ, Mäkelä SM, Airaksinen K, Anglenius H, Ouwehand AC, Maukonen J. Uusitupa HM, et al. Nutrients. 2020 Mar 25;12(4):892. doi: 10.3390/nu12040892. Nutrients. 2020. PMID: 32218248 Free PMC article. Review.
In the search for such strains, the effect of Bifidobacterium animalis subsp. lactis 420 (B420) on gut microbiota and metabolic health, and the mechanisms of actions, has been investigated in a variety of in vitro, pre-clinical, and clinical studies. ...
In the search for such strains, the effect of Bifidobacterium animalis subsp. lactis 420 (B420) on gut microbiota and m …
Lipoteichoic acid from Bifidobacterium animalis subsp. lactis BPL1: a novel postbiotic that reduces fat deposition via IGF-1 pathway.
Balaguer F, Enrique M, Llopis S, Barrena M, Navarro V, Álvarez B, Chenoll E, Ramón D, Tortajada M, Martorell P. Balaguer F, et al. Microb Biotechnol. 2022 Mar;15(3):805-816. doi: 10.1111/1751-7915.13769. Epub 2021 Feb 23. Microb Biotechnol. 2022. PMID: 33620143 Free PMC article.
In this context, supplementation with the probiotic strain Bifidobacterium animalis subsp. lactis BPL1 (CECT8145) has been shown to ameliorate obesity biomarkers. ...
In this context, supplementation with the probiotic strain Bifidobacterium animalis subsp. lactis BPL1 (CECT8145) has b …
Effects of 28-day Bifidobacterium animalis subsp. lactis HN019 supplementation on colonic transit time and gastrointestinal symptoms in adults with functional constipation: A double-blind, randomized, placebo-controlled, and dose-ranging trial.
Ibarra A, Latreille-Barbier M, Donazzolo Y, Pelletier X, Ouwehand AC. Ibarra A, et al. Gut Microbes. 2018;9(3):236-251. doi: 10.1080/19490976.2017.1412908. Epub 2018 Feb 8. Gut Microbes. 2018. PMID: 29227175 Free PMC article. Clinical Trial.
Bifidobacterium animalis subsp. lactis HN019 (HN019) ameliorates chronic idiopathic constipation. ...
Bifidobacterium animalis subsp. lactis HN019 (HN019) ameliorates chronic idiopathic constipation. ...
The therapeutic efficacy of Bifidobacterium animalis subsp. lactis BB-12() in infant colic: A randomised, double blind, placebo-controlled trial.
Nocerino R, De Filippis F, Cecere G, Marino A, Micillo M, Di Scala C, de Caro C, Calignano A, Bruno C, Paparo L, Iannicelli AM, Cosenza L, Maddalena Y, Della Gatta G, Coppola S, Carucci L, Ercolini D, Berni Canani R. Nocerino R, et al. Aliment Pharmacol Ther. 2020 Jan;51(1):110-120. doi: 10.1111/apt.15561. Epub 2019 Dec 3. Aliment Pharmacol Ther. 2020. PMID: 31797399 Free PMC article. Clinical Trial.
AIMS: To assess the rate of infants with a reduction of 50% of mean daily crying duration after 28 days of intervention with the probiotic Bifidobacterium animalis subsp. lactis BB-12() (BB-12). Secondary outcomes were daily number of crying episodes, sleepin …
AIMS: To assess the rate of infants with a reduction of 50% of mean daily crying duration after 28 days of intervention with the probiotic …
Lactobacillus acidophilus DDS-1 and Bifidobacterium lactis UABla-12 Improve Abdominal Pain Severity and Symptomology in Irritable Bowel Syndrome: Randomized Controlled Trial.
Martoni CJ, Srivastava S, Leyer GJ. Martoni CJ, et al. Nutrients. 2020 Jan 30;12(2):363. doi: 10.3390/nu12020363. Nutrients. 2020. PMID: 32019158 Free PMC article. Clinical Trial.
Three hundred and thirty adults, aged 18 to 70 years, with IBS according to Rome IV criteria were allocated (1:1:1) to receive placebo, Lactobacillus acidophilus DDS-1 (1 10(10) CFU/day) or Bifidobacterium animalis subsp. lactis UABla-12 (1 10(10) CFU/day) ov …
Three hundred and thirty adults, aged 18 to 70 years, with IBS according to Rome IV criteria were allocated (1:1:1) to receive placebo, Lact …
Effects of daily consumption of the probiotic Bifidobacterium animalis subsp. lactis CECT 8145 on anthropometric adiposity biomarkers in abdominally obese subjects: a randomized controlled trial.
Pedret A, Valls RM, Calderón-Pérez L, Llauradó E, Companys J, Pla-Pagà L, Moragas A, Martín-Luján F, Ortega Y, Giralt M, Caimari A, Chenoll E, Genovés S, Martorell P, Codoñer FM, Ramón D, Arola L, Solà R. Pedret A, et al. Int J Obes (Lond). 2019 Sep;43(9):1863-1868. doi: 10.1038/s41366-018-0220-0. Epub 2018 Sep 27. Int J Obes (Lond). 2019. PMID: 30262813 Free PMC article. Clinical Trial.
BACKGROUND: The effects of probiotic Bifidobacterium animalis subsp. lactis CECT 8145 (Ba8145) and those of its heat-killed form (h-k Ba8145) on human anthropometric adiposity biomarkers are unknown. ...
BACKGROUND: The effects of probiotic Bifidobacterium animalis subsp. lactis CECT 8145 (Ba8145) and those of its heat-ki …
Efficacy of Bifidobacterium animalis subsp. lactis BL-99 in the treatment of functional dyspepsia: a randomized placebo-controlled clinical trial.
Zhang Q, Li G, Zhao W, Wang X, He J, Zhou L, Zhang X, An P, Liu Y, Zhang C, Zhang Y, Liu S, Zhao L, Liu R, Li Y, Jiang W, Wang X, Wang Q, Fang B, Zhao Y, Ren Y, Niu X, Li D, Shi S, Hung WL, Wang R, Liu X, Ren F. Zhang Q, et al. Nat Commun. 2024 Jan 3;15(1):227. doi: 10.1038/s41467-023-44292-x. Nat Commun. 2024. PMID: 38172093 Free PMC article. Clinical Trial.
This randomized controlled clinical trial (Chinese Clinical Trial Registry, ChiCTR2000041430) assigned 200 FD patients to receive placebo, positive-drug (rabeprazole), or Bifidobacterium animalis subsp. lactis BL-99 (BL-99; low, high doses) for 8-week. The pr …
This randomized controlled clinical trial (Chinese Clinical Trial Registry, ChiCTR2000041430) assigned 200 FD patients to receive placebo, p …
Bifidobacterium animalis subspecies lactis engineered to produce mycosporin-like amino acids in colorectal cancer prevention.
Bozkurt HS, Quigley EM, Kara B. Bozkurt HS, et al. SAGE Open Med. 2019 Jan 22;7:2050312119825784. doi: 10.1177/2050312119825784. eCollection 2019. SAGE Open Med. 2019. PMID: 30719295 Free PMC article. Review.
Disruption of the gut microbiota has been associated with gastrointestinal diseases such as colorectal cancer. The genus Bifidobacterium is considered an important component of the commensal microbiota and plays important roles in several homeostatic functions: immune, neu …
Disruption of the gut microbiota has been associated with gastrointestinal diseases such as colorectal cancer. The genus Bifidobacterium …
Probiotics Bifidobacterium lactis M8 and Lactobacillus rhamnosus M9 prevent high blood pressure via modulating the gut microbiota composition and host metabolic products.
Zhang Y, Zheng T, Ma D, Shi P, Zhang H, Li J, Sun Z. Zhang Y, et al. mSystems. 2023 Dec 21;8(6):e0033123. doi: 10.1128/msystems.00331-23. Epub 2023 Oct 19. mSystems. 2023. PMID: 37855616 Free PMC article.
The global understanding of the gut microbiome for hypertension may provide important insights into the prevention. Bifidobacterium lactis M8 and Lactobacillus rhamnosus M9 originated from human breast milk, were able to decrease blood pressure, and modified metabol …
The global understanding of the gut microbiome for hypertension may provide important insights into the prevention. Bifidobacterium …
2,154 results